Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): An ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

The RIGHT-2 Investigators

Research output: Contribution to journalArticlepeer-review

Search results